Impaired	O
CK1	O
delta	O
activity	O
attenuates	O
SV40	O
-	O
induced	O
cellular	B-Cell
transformation	O
in	O
vitro	O
and	O
mouse	O
mammary	B-Organ
carcinogenesis	O
in	O
vivo	O
.	O

Simian	O
virus	O
40	O
(	O
SV40	O
)	O
is	O
a	O
powerful	O
tool	O
to	O
study	O
cellular	B-Cell
transformation	O
in	O
vitro	O
,	O
as	O
well	O
as	O
tumor	B-Cancer
development	O
and	O
progression	O
in	O
vivo	O
.	O

Various	O
cellular	B-Cell
kinases	O
,	O
among	O
them	O
members	O
of	O
the	O
CK1	O
family	O
,	O
play	O
an	O
important	O
role	O
in	O
modulating	O
the	O
transforming	O
activity	O
of	O
SV40	O
,	O
including	O
the	O
transforming	O
activity	O
of	O
T	O
-	O
Ag	O
,	O
the	O
major	O
transforming	O
protein	O
of	O
SV40	O
,	O
itself	O
.	O

Here	O
we	O
characterized	O
the	O
effects	O
of	O
mutant	O
CK1delta	O
variants	O
with	O
impaired	O
kinase	O
activity	O
on	O
SV40	O
-	O
induced	O
cell	B-Cell
transformation	O
in	O
vitro	O
,	O
and	O
on	O
SV40	O
-	O
induced	O
mammary	B-Organ
carcinogenesis	O
in	O
vivo	O
in	O
a	O
transgenic	O
/	O
bi	O
-	O
transgenic	O
mouse	O
model	O
.	O

CK1delta	O
mutants	O
exhibited	O
a	O
reduced	O
kinase	O
activity	O
compared	O
to	O
wtCK1delta	O
in	O
in	O
vitro	O
kinase	O
assays	O
.	O

Molecular	O
modeling	O
studies	O
suggested	O
that	O
mutation	O
N172D	O
,	O
located	O
within	O
the	O
substrate	O
binding	O
region	O
,	O
is	O
mainly	O
responsible	O
for	O
impaired	O
mutCK1delta	O
activity	O
.	O

When	O
stably	O
over	O
-	O
expressed	O
in	O
maximal	O
transformed	O
SV	B-Cell
-	I-Cell
52	I-Cell
cells	I-Cell
,	O
CK1delta	O
mutants	O
induced	O
reversion	O
to	O
a	O
minimal	O
transformed	O
phenotype	O
by	O
dominant	O
-	O
negative	O
interference	O
with	O
endogenous	O
wtCK1delta	O
.	O

To	O
characterize	O
the	O
effects	O
of	O
CK1delta	O
on	O
SV40	O
-	O
induced	O
mammary	B-Organ
carcinogenesis	O
,	O
we	O
generated	O
transgenic	O
mice	O
expressing	O
mutant	O
CK1delta	O
under	O
the	O
control	O
of	O
the	O
whey	O
acidic	O
protein	O
(	O
WAP	O
)	O
gene	O
promoter	O
,	O
and	O
crossed	O
them	O
with	O
SV40	O
transgenic	O
WAP	O
-	O
T	O
-	O
antigen	O
(	O
WAP	O
-	O
T	O
)	O
mice	O
.	O

Both	O
WAP	O
-	O
T	O
mice	O
as	O
well	O
as	O
WAP	O
-	O
mutCK1delta	O
/	O
WAP	O
-	O
T	O
bi	O
-	O
transgenic	O
mice	O
developed	O
breast	B-Cancer
cancer	I-Cancer
.	O

However	O
,	O
tumor	B-Cancer
incidence	O
was	O
lower	O
and	O
life	O
span	O
was	O
significantly	O
longer	O
in	O
WAP	O
-	O
mutCK1delta	O
/	O
WAP	O
-	O
T	O
bi	O
-	O
transgenic	O
animals	O
.	O

The	O
reduced	O
CK1delta	O
activity	O
did	O
not	O
affect	O
early	O
lesion	B-Pathological_formation
formation	O
during	O
tumorigenesis	O
,	O
suggesting	O
that	O
impaired	O
CK1delta	O
activity	O
reduces	O
the	O
probability	O
for	O
outgrowth	O
of	O
in	B-Cancer
situ	I-Cancer
carcinomas	I-Cancer
to	O
invasive	B-Cancer
carcinomas	I-Cancer
.	O

The	O
different	O
tumorigenic	O
potential	O
of	O
SV40	O
in	O
WAP	O
-	O
T	O
and	O
WAP	O
-	O
mutCK1delta	O
/	O
WAP	O
-	O
T	O
tumors	B-Cancer
was	O
also	O
reflected	O
by	O
a	O
significantly	O
different	O
expression	O
of	O
various	O
genes	O
known	O
to	O
be	O
involved	O
in	O
tumor	B-Cancer
progression	O
,	O
specifically	O
of	O
those	O
involved	O
in	O
wnt	O
-	O
signaling	O
and	O
DNA	O
repair	O
.	O

Our	O
data	O
show	O
that	O
inactivating	O
mutations	O
in	O
CK1delta	O
impair	O
SV40	O
-	O
induced	O
cellular	B-Cell
transformation	O
in	O
vitro	O
and	O
mouse	O
mammary	B-Organ
carcinogenesis	O
in	O
vivo	O
.	O

